Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 134 entries
Sorted by: Best Match Show Resources per page
A pilot test of a new tool for remote blood pressure monitoring.

Journal of telemedicine and telecare

Boman K, Brenander A, Gustavsson M, Furberg CD.
PMID: 24833661
J Telemed Telecare. 2014 Jul;20(5):239-241. doi: 10.1177/1357633X14536348. Epub 2014 May 15.

We conducted a pilot trial of a remote blood pressure (BP) monitoring system, in which subjects measured their own BP at a primary healthcare centre. The data were wirelessly transmitted to the general practitioner. A total of 132 subjects...

Cite
Boman K, Brenander A, Gustavsson M, et al. A pilot test of a new tool for remote blood pressure monitoring. J Telemed Telecare. 2014;20(5):239-241doi: 10.1177/1357633X14536348.
Boman, K., Brenander, A., Gustavsson, M., & Furberg, C. D. (2014). A pilot test of a new tool for remote blood pressure monitoring. Journal of telemedicine and telecare, 20(5), 239-241. https://doi.org/10.1177/1357633X14536348
Boman, Kurt, et al. "A pilot test of a new tool for remote blood pressure monitoring." Journal of telemedicine and telecare vol. 20,5 (2014): 239-241. doi: https://doi.org/10.1177/1357633X14536348
Boman K, Brenander A, Gustavsson M, Furberg CD. A pilot test of a new tool for remote blood pressure monitoring. J Telemed Telecare. 2014 Jul;20(5):239-241. doi: 10.1177/1357633X14536348. Epub 2014 May 15. PMID: 24833661.
Copy Download .nbib Format: NLM
Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US.

Pharmaceutical medicine

Bahk CY, Goshgarian M, Donahue K, Freifeld CC, Menone CM, Pierce CE, Rodriguez H, Brownstein JS, Furberg R, Dasgupta N.
PMID: 26635479
Pharmaceut Med. 2015;29(6):331-340. doi: 10.1007/s40290-015-0106-6. Epub 2015 Aug 05.

BACKGROUND: Preparing and submitting a voluntary adverse event (AE) report to the US Food and Drug Administration (FDA) for a medical device typically takes 40 min. User-friendly Web and mobile reporting apps may increase efficiency. Further, coupled with strategies...

Cite
Bahk CY, Goshgarian M, Donahue K, et al. Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US. Pharmaceut Med. 2015;29(6):331-340doi: 10.1007/s40290-015-0106-6.
Bahk, C. Y., Goshgarian, M., Donahue, K., Freifeld, C. C., Menone, C. M., Pierce, C. E., Rodriguez, H., Brownstein, J. S., Furberg, R., & Dasgupta, N. (2015). Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US. Pharmaceutical medicine, 29(6), 331-340. https://doi.org/10.1007/s40290-015-0106-6
Bahk, Chi Y, et al. "Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US." Pharmaceutical medicine vol. 29,6 (2015): 331-340. doi: https://doi.org/10.1007/s40290-015-0106-6
Bahk CY, Goshgarian M, Donahue K, Freifeld CC, Menone CM, Pierce CE, Rodriguez H, Brownstein JS, Furberg R, Dasgupta N. Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US. Pharmaceut Med. 2015;29(6):331-340. doi: 10.1007/s40290-015-0106-6. Epub 2015 Aug 05. PMID: 26635479; PMCID: PMC4656696.
Copy Download .nbib Format: NLM
Women's and clinicians perspectives of presentation with reduced fetal movements: a qualitative study.

BMC pregnancy and childbirth

Smyth RM, Taylor W, Heazell AE, Furber C, Whitworth M, Lavender T.
PMID: 27671523
BMC Pregnancy Childbirth. 2016 Sep 26;16(1):280. doi: 10.1186/s12884-016-1074-x.

BACKGROUND: Worldwide maternal perception of fetal movements has been used for many years to evaluate fetal wellbeing. It is intuitively regarded as an expression of fetal well-being as pregnancies in which women consistently report regular fetal movements have very...

Cite
Smyth RM, Taylor W, Heazell AE, et al. Women's and clinicians perspectives of presentation with reduced fetal movements: a qualitative study. BMC Pregnancy Childbirth. 2016;16(1):280doi: 10.1186/s12884-016-1074-x.
Smyth, R. M., Taylor, W., Heazell, A. E., Furber, C., Whitworth, M., & Lavender, T. (2016). Women's and clinicians perspectives of presentation with reduced fetal movements: a qualitative study. BMC pregnancy and childbirth, 16(1), 280. https://doi.org/10.1186/s12884-016-1074-x
Smyth, R M D, et al. "Women's and clinicians perspectives of presentation with reduced fetal movements: a qualitative study." BMC pregnancy and childbirth vol. 16,1 (2016): 280. doi: https://doi.org/10.1186/s12884-016-1074-x
Smyth RM, Taylor W, Heazell AE, Furber C, Whitworth M, Lavender T. Women's and clinicians perspectives of presentation with reduced fetal movements: a qualitative study. BMC Pregnancy Childbirth. 2016 Sep 26;16(1):280. doi: 10.1186/s12884-016-1074-x. PMID: 27671523; PMCID: PMC5037887.
Copy Download .nbib Format: NLM
Sleep and Motor Learning: Implications for Physical Rehabilitation After Stroke.

Frontiers in neurology

Gudberg C, Johansen-Berg H.
PMID: 26635718
Front Neurol. 2015 Nov 24;6:241. doi: 10.3389/fneur.2015.00241. eCollection 2015.

Sleep is essential for healthy brain function and plasticity underlying learning and memory. In the context of physical impairment such as following a stroke, sleep may be particularly important for supporting critical recovery of motor function through similar processes...

Cite
Gudberg C, Johansen-Berg H. Sleep and Motor Learning: Implications for Physical Rehabilitation After Stroke. Front Neurol. 2015;6:241doi: 10.3389/fneur.2015.00241.
Gudberg, C., & Johansen-Berg, H. (2015). Sleep and Motor Learning: Implications for Physical Rehabilitation After Stroke. Frontiers in neurology, 6241. https://doi.org/10.3389/fneur.2015.00241
Gudberg, Christel, and Johansen-Berg, Heidi. "Sleep and Motor Learning: Implications for Physical Rehabilitation After Stroke." Frontiers in neurology vol. 6 (2015): 241. doi: https://doi.org/10.3389/fneur.2015.00241
Gudberg C, Johansen-Berg H. Sleep and Motor Learning: Implications for Physical Rehabilitation After Stroke. Front Neurol. 2015 Nov 24;6:241. doi: 10.3389/fneur.2015.00241. eCollection 2015. PMID: 26635718; PMCID: PMC4656813.
Copy Download .nbib Format: NLM
Usability Testing and Adaptation of the Pediatric Cardiovascular Risk Reduction Clinical Decision Support Tool.

JMIR human factors

Williams PA, Furberg RD, Bagwell JE, LaBresh KA.
PMID: 27328761
JMIR Hum Factors. 2016 Jun 21;3(1):e17. doi: 10.2196/humanfactors.5440.

BACKGROUND: Cardiovascular disease (CVD) is 1 of the leading causes of death, years of life lost, and disability-adjusted years of life lost worldwide. CVD prevention for children and teens is needed, as CVD risk factors and behaviors beginning in...

Cite
Williams PA, Furberg RD, Bagwell JE, et al. Usability Testing and Adaptation of the Pediatric Cardiovascular Risk Reduction Clinical Decision Support Tool. JMIR Hum Factors. 2016;3(1):e17doi: 10.2196/humanfactors.5440.
Williams, P. A., Furberg, R. D., Bagwell, J. E., & LaBresh, K. A. (2016). Usability Testing and Adaptation of the Pediatric Cardiovascular Risk Reduction Clinical Decision Support Tool. JMIR human factors, 3(1), e17. https://doi.org/10.2196/humanfactors.5440
Williams, Pamela A, et al. "Usability Testing and Adaptation of the Pediatric Cardiovascular Risk Reduction Clinical Decision Support Tool." JMIR human factors vol. 3,1 (2016): e17. doi: https://doi.org/10.2196/humanfactors.5440
Williams PA, Furberg RD, Bagwell JE, LaBresh KA. Usability Testing and Adaptation of the Pediatric Cardiovascular Risk Reduction Clinical Decision Support Tool. JMIR Hum Factors. 2016 Jun 21;3(1):e17. doi: 10.2196/humanfactors.5440. PMID: 27328761; PMCID: PMC4933802.
Copy Download .nbib Format: NLM
Single-catalyst high-weight% hydrogen storage in an N-heterocycle synthesized from lignin hydrogenolysis products and ammonia.

Nature communications

Forberg D, Schwob T, Zaheer M, Friedrich M, Miyajima N, Kempe R.
PMID: 27762267
Nat Commun. 2016 Oct 20;7:13201. doi: 10.1038/ncomms13201.

Large-scale energy storage and the utilization of biomass as a sustainable carbon source are global challenges of this century. The reversible storage of hydrogen covalently bound in chemical compounds is a particularly promising energy storage technology. For this, compounds...

Cite
Forberg D, Schwob T, Zaheer M, et al. Single-catalyst high-weight% hydrogen storage in an N-heterocycle synthesized from lignin hydrogenolysis products and ammonia. Nat Commun. 2016;7:13201doi: 10.1038/ncomms13201.
Forberg, D., Schwob, T., Zaheer, M., Friedrich, M., Miyajima, N., & Kempe, R. (2016). Single-catalyst high-weight% hydrogen storage in an N-heterocycle synthesized from lignin hydrogenolysis products and ammonia. Nature communications, 713201. https://doi.org/10.1038/ncomms13201
Forberg, Daniel, et al. "Single-catalyst high-weight% hydrogen storage in an N-heterocycle synthesized from lignin hydrogenolysis products and ammonia." Nature communications vol. 7 (2016): 13201. doi: https://doi.org/10.1038/ncomms13201
Forberg D, Schwob T, Zaheer M, Friedrich M, Miyajima N, Kempe R. Single-catalyst high-weight% hydrogen storage in an N-heterocycle synthesized from lignin hydrogenolysis products and ammonia. Nat Commun. 2016 Oct 20;7:13201. doi: 10.1038/ncomms13201. PMID: 27762267; PMCID: PMC5080437.
Copy Download .nbib Format: NLM
Current Controlled Trials in Cardiovascular Medicine: a new journal for a new age (http://cvm.controlled-trials.com).

Current controlled trials in cardiovascular medicine

Furberg C, Pitt B.
PMID: 11714396
Curr Control Trials Cardiovasc Med. 2000;1(1):1-2. doi: 10.1186/cvm-1-1-001.

No abstract available.

Cite
Furberg C, Pitt B. Current Controlled Trials in Cardiovascular Medicine: a new journal for a new age (http://cvm.controlled-trials.com). Curr Control Trials Cardiovasc Med. 2000;1(1):1-2doi: 10.1186/cvm-1-1-001.
Furberg, C., & Pitt, B. (2000). Current Controlled Trials in Cardiovascular Medicine: a new journal for a new age (http://cvm.controlled-trials.com). Current controlled trials in cardiovascular medicine, 1(1), 1-2. https://doi.org/10.1186/cvm-1-1-001
Furberg, Curt, and Pitt, Bertram. "Current Controlled Trials in Cardiovascular Medicine: a new journal for a new age (http://cvm.controlled-trials.com)." Current controlled trials in cardiovascular medicine vol. 1,1 (2000): 1-2. doi: https://doi.org/10.1186/cvm-1-1-001
Furberg C, Pitt B. Current Controlled Trials in Cardiovascular Medicine: a new journal for a new age (http://cvm.controlled-trials.com). Curr Control Trials Cardiovasc Med. 2000;1(1):1-2. doi: 10.1186/cvm-1-1-001. PMID: 11714396; PMCID: PMC59586.
Copy Download .nbib Format: NLM
Lessons From the Cardiovascular Health Study Question and Answer Format.

The American journal of geriatric cardiology

Furberg CD, Steingart RM.
PMID: 11416345
Am J Geriatr Cardiol. 1995 Jul;4(4):53-55.

No abstract available.

Cite
Furberg CD, Steingart RM. Lessons From the Cardiovascular Health Study Question and Answer Format. Am J Geriatr Cardiol. 1995;4(4):53-55
Furberg, C. D., & Steingart, R. M. (1995). Lessons From the Cardiovascular Health Study Question and Answer Format. The American journal of geriatric cardiology, 4(4), 53-55.
Furberg, Curt D., and Steingart, Richard M.. "Lessons From the Cardiovascular Health Study Question and Answer Format." The American journal of geriatric cardiology vol. 4,4 (1995): 53-55.
Furberg CD, Steingart RM. Lessons From the Cardiovascular Health Study Question and Answer Format. Am J Geriatr Cardiol. 1995 Jul;4(4):53-55. PMID: 11416345.
Copy Download .nbib Format: NLM
The worm turns to vinculin function.

Current biology : CB

Fyrberg E.
PMID: 15336057
Curr Biol. 1992 Jan;2(1):1-3. doi: 10.1016/0960-9822(92)90398-t.

No abstract available.

Cite
Fyrberg E. The worm turns to vinculin function. Curr Biol. 1992;2(1):1-3doi: 10.1016/0960-9822(92)90398-t.
Fyrberg, E. (1992). The worm turns to vinculin function. Current biology : CB, 2(1), 1-3. https://doi.org/10.1016/0960-9822(92)90398-t
Fyrberg, E. "The worm turns to vinculin function." Current biology : CB vol. 2,1 (1992): 1-3. doi: https://doi.org/10.1016/0960-9822(92)90398-t
Fyrberg E. The worm turns to vinculin function. Curr Biol. 1992 Jan;2(1):1-3. doi: 10.1016/0960-9822(92)90398-t. PMID: 15336057.
Copy Download .nbib Format: NLM
Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women.

Journal of oncology

Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, Zirpoli G, Pawlish K, Godbold J, Furberg H, Fatone A, Valdimarsdottir H, Yao S, Li Y, Hwang H, Davis W, Roberts M, Sucheston L, Demissie K, Amend KL, Tartter P, Reilly J, Pace BW, Rohan T, Sparano J, Raptis G, Castaldi M, Estabrook A, Feldman S, Weltz C, Kemeny M.
PMID: 19865486
J Oncol. 2009;2009:871250. doi: 10.1155/2009/871250. Epub 2009 Oct 25.

Breast cancer in African-American (AA) women occurs at an earlier age than in European-American (EA) women and is more likely to have aggressive features associated with poorer prognosis, such as high-grade and negative estrogen receptor (ER) status. The mechanisms...

Cite
Ambrosone CB, Ciupak GL, Bandera EV, et al. Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. J Oncol. 2009;2009:871250doi: 10.1155/2009/871250.
Ambrosone, C. B., Ciupak, G. L., Bandera, E. V., Jandorf, L., Bovbjerg, D. H., Zirpoli, G., Pawlish, K., Godbold, J., Furberg, H., Fatone, A., Valdimarsdottir, H., Yao, S., Li, Y., Hwang, H., Davis, W., Roberts, M., Sucheston, L., Demissie, K., Amend, K. L., Tartter, P., Reilly, J., Pace, B. W., Rohan, T., Sparano, J., Raptis, G., Castaldi, M., Estabrook, A., Feldman, S., Weltz, C., & Kemeny, M. (2009). Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. Journal of oncology, 2009871250. https://doi.org/10.1155/2009/871250
Ambrosone, Christine B, et al. "Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women." Journal of oncology vol. 2009 (2009): 871250. doi: https://doi.org/10.1155/2009/871250
Ambrosone CB, Ciupak GL, Bandera EV, Jandorf L, Bovbjerg DH, Zirpoli G, Pawlish K, Godbold J, Furberg H, Fatone A, Valdimarsdottir H, Yao S, Li Y, Hwang H, Davis W, Roberts M, Sucheston L, Demissie K, Amend KL, Tartter P, Reilly J, Pace BW, Rohan T, Sparano J, Raptis G, Castaldi M, Estabrook A, Feldman S, Weltz C, Kemeny M. Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American Women. J Oncol. 2009;2009:871250. doi: 10.1155/2009/871250. Epub 2009 Oct 25. PMID: 19865486; PMCID: PMC2766507.
Copy Download .nbib Format: NLM
Five years of Trials.

Trials

Altman DG, Hrynaszkiewicz I, Furberg CD, Grimshaw JM, Rothwell PM.
PMID: 22112799
Trials. 2011 Nov 23;12:248. doi: 10.1186/1745-6215-12-248.

This editorial marks the launch of a special collection of articles highlighting 'Five years of Trials' (http://www.trialsjournal.com/series/5years). The journal's achievements on its objectives since 2006 are described and some of the challenges still ahead are outlined - in particular...

Cite
Altman DG, Hrynaszkiewicz I, Furberg CD, et al. Five years of Trials. Trials. 2011;12:248doi: 10.1186/1745-6215-12-248.
Altman, D. G., Hrynaszkiewicz, I., Furberg, C. D., Grimshaw, J. M., & Rothwell, P. M. (2011). Five years of Trials. Trials, 12248. https://doi.org/10.1186/1745-6215-12-248
Altman, Douglas G, et al. "Five years of Trials." Trials vol. 12 (2011): 248. doi: https://doi.org/10.1186/1745-6215-12-248
Altman DG, Hrynaszkiewicz I, Furberg CD, Grimshaw JM, Rothwell PM. Five years of Trials. Trials. 2011 Nov 23;12:248. doi: 10.1186/1745-6215-12-248. PMID: 22112799; PMCID: PMC3254076.
Copy Download .nbib Format: NLM
Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System.

Journal of oncology

Gulliksen A, Keegan H, Martin C, O'Leary J, Solli LA, Falang IM, Grønn P, Karlgård A, Mielnik MM, Johansen IR, Tofteberg TR, Baier T, Gransee R, Drese K, Hansen-Hagge T, Riegger L, Koltay P, Zengerle R, Karlsen F, Ausen D, Furuberg L.
PMID: 22235204
J Oncol. 2012;2012:905024. doi: 10.1155/2012/905024. Epub 2011 Dec 22.

The paper presents the development of a "proof-of-principle" hands-free and self-contained diagnostic platform for detection of human papillomavirus (HPV) E6/E7 mRNA in clinical specimens. The automated platform performs chip-based sample preconcentration, nucleic acid extraction, amplification, and real-time fluorescent detection...

Cite
Gulliksen A, Keegan H, Martin C, et al. Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System. J Oncol. 2011;2012:905024doi: 10.1155/2012/905024.
Gulliksen, A., Keegan, H., Martin, C., O'Leary, J., Solli, L. A., Falang, I. M., Grønn, P., Karlgård, A., Mielnik, M. M., Johansen, I. R., Tofteberg, T. R., Baier, T., Gransee, R., Drese, K., Hansen-Hagge, T., Riegger, L., Koltay, P., Zengerle, R., Karlsen, F., Ausen, D., & Furuberg, L. (2012). Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System. Journal of oncology, 2012905024. https://doi.org/10.1155/2012/905024
Gulliksen, Anja, et al. "Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System." Journal of oncology vol. 2012 (2012): 905024. doi: https://doi.org/10.1155/2012/905024
Gulliksen A, Keegan H, Martin C, O'Leary J, Solli LA, Falang IM, Grønn P, Karlgård A, Mielnik MM, Johansen IR, Tofteberg TR, Baier T, Gransee R, Drese K, Hansen-Hagge T, Riegger L, Koltay P, Zengerle R, Karlsen F, Ausen D, Furuberg L. Towards a "Sample-In, Answer-Out" Point-of-Care Platform for Nucleic Acid Extraction and Amplification: Using an HPV E6/E7 mRNA Model System. J Oncol. 2012;2012:905024. doi: 10.1155/2012/905024. Epub 2011 Dec 22. PMID: 22235204; PMCID: PMC3253481.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 134 entries